Gündüz, S. Et Al. 2013. YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy. 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity , (Amsterdam, Netherlands), 604.

Gündüz, S., ÖZGÜR, Ö., ERKILIÇ, M., BOZCUK, H. Ş., & SİNDEL, H. T., (2013). YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy . 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity (pp.604). Amsterdam, Netherlands

Gündüz, ŞEYDA Et Al. "YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy," 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity, Amsterdam, Netherlands, 2013

Gündüz, ŞEYDA Et Al. "YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy." 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity , Amsterdam, Netherlands, pp.604, 2013

Gündüz, S. Et Al. (2013) . "YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy." 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity , Amsterdam, Netherlands, p.604.

@conferencepaper{conferencepaper, author={ŞEYDA GÜNDÜZ Et Al. }, title={YTTRIUM-90 (y-90) radioembolization in patients with unresectable liver metastases: Determining the factors that lead to treatment efficacy}, congress name={17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity}, city={Amsterdam}, country={Netherlands}, year={2013}, pages={604} }